Skip to main content
Lesedauer ca. 2 Min. 7. October 2024

Electrostimulation as a Therapy Option

Therapy & Application Company & Network Research & Evidence
Okuvision: Doctor's Consultation – Hands of Patient and Doctor on the Table

Electrostimulation as a Therapy Option –
Current Ophthalmological Guideline Points to Electrostimulation for Retinitis pigmentosa

In the revision of their Guideline 25 (now Guideline AWMF 045/23) for Hereditary diseases of the retina, choroid, and optic pathway, the German Ophthalmological Society (DOG), the Retinological Society (RG), and the Professional Association of German Ophthalmologists (BVA) point to electrostimulation as an option for therapy in Retinitis pigmentosa (RP). The study, which began in May as part of the G-BA’s trial study directive, is also mentioned as a possible application context.

Through the revision of the guideline, ophthalmologists now have concrete courses of action for the symptomatic treatment of hereditary retinal dystrophies with electrostimulation for RP and gene therapy for LCA.

You can find the original guideline text as a PDF for download:

– on the website of the Retinological Society
– on the website of the German Ophthalmological Society

Learn more about the efficacy and safety of OkuStim® therapy

To the TES study situation

Insights onTherapy, Research & Company

The OkuStim® therapy was developed for patients with degenerative retinal diseases such as retinitis pigmentosa. It allows you to slow down the progression of the disease. At the heart of the therapy is the OkuStim® system, which enables you to independently stimulate your retina with weak electrical currents at home.